These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 28247107)

  • 1. Effect of collagen vascular disease-associated interstitial lung disease on the outcomes of lung cancer surgery.
    Maeda H; Kanzaki M; Sakamoto K; Isaka T; Oyama K; Murasugi M; Onuki T
    Surg Today; 2017 Sep; 47(9):1072-1079. PubMed ID: 28247107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.
    Tachikawa R; Tomii K; Ueda H; Nagata K; Nanjo S; Sakurai A; Otsuka K; Kaji R; Hayashi M; Katakami N; Imai Y
    Respiration; 2012; 83(1):20-7. PubMed ID: 21912082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-endothelial cell antibodies in patients with interstitial lung diseases.
    Matsui T; Inui N; Suda T; Chida K
    Respir Med; 2008 Jan; 102(1):128-33. PubMed ID: 17851060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small-cell lung cancer: analysis of risk factors.
    Voltolini L; Bongiolatti S; Luzzi L; Bargagli E; Fossi A; Ghiribelli C; Rottoli P; Gotti G
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):e17-23. PubMed ID: 23129356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonspecific interstitial pneumonia preceding diagnosis of collagen vascular disease.
    Kono M; Nakamura Y; Yoshimura K; Enomoto Y; Oyama Y; Hozumi H; Enomoto N; Fujisawa T; Inui N; Hamada E; Colby TV; Maekawa M; Suda T
    Respir Med; 2016 Aug; 117():40-7. PubMed ID: 27492512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.
    Tsutani Y; Mimura T; Kai Y; Ito M; Misumi K; Miyata Y; Okada M
    J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1089-1096.e1. PubMed ID: 28483268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease.
    Kato M; Shukuya T; Takahashi F; Mori K; Suina K; Asao T; Kanemaru R; Honma Y; Muraki K; Sugano K; Shibayama R; Koyama R; Shimada N; Takahashi K
    BMC Cancer; 2014 Jul; 14():508. PubMed ID: 25012241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lung cancer combined with idiopathic interstitial pneumonias].
    Imakiire T; Koike T; Watanabe T; Saito Y; Hirono T
    Kyobu Geka; 2005 Jan; 58(1):4-8. PubMed ID: 15678958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is operation safe for lung cancer patients with interstitial lung disease on computed tomography?
    Tang H; Ren Y; She Y; Dai C; Wang T; Su H; Sun W; Jiang G; Chen C
    Ther Adv Respir Dis; 2020; 14():1753466620971137. PubMed ID: 33167797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival after complete resection of non-small-cell lung cancer in patients with interstitial lung disease.
    Sekihara K; Aokage K; Oki T; Omori T; Katsumata S; Ueda T; Miyoshi T; Goto M; Nakasone S; Ichikawa T; Hishida T; Yoshida J; Hisakane K; Goto K; Tsuboi M
    Interact Cardiovasc Thorac Surg; 2018 Apr; 26(4):638-643. PubMed ID: 29272403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ATS/ERS/JRS/ALAT statement "IPF by HRCT" could predict acute exacerbation of interstitial lung disease in non-small cell lung cancer.
    Asai N; Katsuda E; Hamanaka R; Kosaka K; Matsubara A; Nishimura M; Tanaka H; Yokoe N; Takahashi A; Yamaguchi E; Kubo A
    Tumori; 2017 Jan; 103(1):60-65. PubMed ID: 27791236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer.
    Masuda T; Hirano C; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):131-139. PubMed ID: 29143072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interstitial Lung Disease-Gender-Age-Physiology Index Can Predict the Prognosis in Surgically Resected Patients with Interstitial Lung Disease and Concomitant Lung Cancer.
    Ueno F; Kitaguchi Y; Shiina T; Asaka S; Yasuo M; Wada Y; Kinjo T; Yoshizawa A; Hanaoka M
    Respiration; 2020; 99(1):9-18. PubMed ID: 31554007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
    Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
    Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer.
    Kenmotsu H; Naito T; Kimura M; Ono A; Shukuya T; Nakamura Y; Tsuya A; Kaira K; Murakami H; Takahashi T; Endo M; Yamamoto N
    J Thorac Oncol; 2011 Jul; 6(7):1242-6. PubMed ID: 21623239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic subgroups of nonspecific interstitial pneumonia: differential diagnosis from other idiopathic interstitial pneumonias on high-resolution computed tomography.
    Tsubamoto M; Müller NL; Johkoh T; Ichikado K; Taniguchi H; Kondoh Y; Fujimoto K; Arakawa H; Koyama M; Kozuka T; Inoue A; Sumikawa M; Murai S; Honda O; Tomiyama N; Hamada S; Nakamura H
    J Comput Assist Tomogr; 2005; 29(6):793-800. PubMed ID: 16272854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ILD-NSCLC-GAP index scoring and staging system for patients with non-small cell lung cancer and interstitial lung disease.
    Kobayashi H; Naito T; Omae K; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Murakami H; Endo M; Takahashi T
    Lung Cancer; 2018 Jul; 121():48-53. PubMed ID: 29858026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What factors determine the survival of patients with an acute exacerbation of interstitial lung disease after lung cancer resection?
    Miyajima M; Watanabe A; Sato T; Teramukai S; Ebina M; Kishi K; Sugiyama Y; Kondo H; Kobayashi S; Takahashi Y; Ito H; Yamamoto R; Sawada S; Fujimori H; Okabe K; Arikura J; Shintani Y; Nakamura H; Toyooka S; Hasumi T; Watanabe T; Hata Y; Iwata H; Aoki M; Funai K; Inoue S; Kawashima O; Iida T; Date H
    Surg Today; 2018 Apr; 48(4):404-415. PubMed ID: 29124429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of coexisting lung diseases on outcomes in patients with pathological Stage I non-small-cell lung cancer.
    Tao H; Onoda H; Okabe K; Matsumoto T
    Interact Cardiovasc Thorac Surg; 2018 Jun; 26(6):1009-1015. PubMed ID: 29394349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference in benefit of chemotherapy between small cell lung cancer patients with interstitial pneumonia and patients with non-small cell lung cancer.
    Kashiwabara K; Semba H; Fujii S; Tsumura S; Aoki R
    Anticancer Res; 2015 Feb; 35(2):1065-71. PubMed ID: 25667495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.